Oncolin Therapeutics, Inc. Board Not Able To Meet The Obligations Of An Early Stage Biotech Company Such As Intertech Bio
3/6/2009 9:25:24 AM
More...
|
Oncolin Therapeutics, Inc. Announces Appointment of Chair of Scientific Advisory Committee
7/17/2008 11:09:12 AM
More...
|
Oncolin Therapeutics, Inc. Announces the Discovery of a New More Effective Anti-Cancer Treatment in Experimental Brain Tumor Models
6/30/2008 9:46:07 AM
More...
|
Oncolin Therapeutics, Inc. Appoints Member of National Cancer Institute Advisory Board to its Scientific Advisory Board
6/23/2008 11:10:54 AM
More...
|
Oncolin Therapeutics, Inc. Announces Its Cancer Technology Will Be Presented at the 20th EORTC-NCI-AACR Symposium
6/19/2008 10:17:54 AM
More...
|
Oncolin Therapeutics, Inc. Signs Agreement with Leading Cancer Center
6/10/2008 9:22:44 AM
More...
|
Oncolin Therapeutics, Inc. Announces Its New 'Super Cell Blocker', ONC-127, Has Shown Effectiveness in Treating Cancer
5/14/2008 8:57:59 AM
More...
|
Oncolin Therapeutics, Inc. Announces That Dr. Randall K. Johnson Has Agreed to Join Its Scientific Advisory Board
5/6/2008 9:22:23 AM
More...
|
Oncolin Therapeutics, Inc. Announces the Addition of Dr. Sandra Silberman to Its Scientific Advisory Board
4/17/2008 9:50:01 AM
More...
|
Oncolin Therapeutics, Inc. Announces Its Lead Technology Has Shown to Be Effective in Treating Cancer in Animal Models
4/15/2008 10:11:17 AM
More...
|
|